Novel approach to nipple reconstruction: First male FixNip prosthesis implantation.

BACKGROUND AND

INTRODUCTION

Nipple-areola complex (NAC) reconstruction remains a challenging aspect of breast reconstruction, particularly due to long-term loss of nipple projection and variability in aesthetic outcomes associated with traditional techniques. The FixNip nipple prosthesis is a novel implant-based device designed to provide stable projection and improved aesthetic results. We report the first documented clinical application of the FixNip prosthesis in a male patient following mastectomy.

CASE PRESENTATION: A 53-year-old male patient with a history of left-sided mastectomy for breast cancer underwent delayed NAC reconstruction using the FixNip prosthesis after prior autologous reconstruction with lipofilling. The prosthesis, composed of a nitinol framework enclosed within a silicone cap, was implanted through a small subcutaneous pocket under local anesthesia. Postoperative follow-up was performed at 1 week, 1 month, 6 months, and 12 months.

RESULTS

The procedure was completed without intraoperative or postoperative complications. At 6-month follow-up, the patient demonstrated stable nipple projection, satisfactory symmetry, and excellent aesthetic integration with the contralateral NAC. No signs of infection, implant displacement, skin necrosis, or adverse local reactions were observed. The patient reported high satisfaction with the aesthetic outcome and significant improvement in body image and quality of life.

DISCUSSION AND

CONCLUSIONS

The FixNip prosthesis appears to be a safe and effective option for NAC reconstruction in selected patients, offering stable long-term projection with minimal surgical morbidity. This first reported application in a male patient highlights the potential role of implant-based NAC reconstruction in improving aesthetic and psychological outcomes following mastectomy. Further studies with larger patient cohorts and longer follow-up are needed to confirm long-term safety and efficacy.